{"url_path":"/sec/lmed/8-k/2026-05-08/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 — FINANCIAL STATEMENTS AND EXHIBITS.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-002848-index.html","accession_number":"0001477932-26-002848","cik":"0001477960","ticker":"LMED","issuer_name":"LataMed AI Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-002848-index.html","primary_entity_key":"0001477960","primary_entity_name":"LataMed AI Corp."},"word_count":84,"has_tables":true,"body_markdown":"**ITEM 9.01 — FINANCIAL STATEMENTS AND EXHIBITS.**\n\n \n\n**(d) Exhibits**\n\n \n\n**Exhibit No.**\n\n \n\n**Description**\n\n[3.1](cctc_ex31.htm)\n\n \n\n[Certificate of Designation of Series C Voting Preferred Stock](cctc_ex31.htm)\n\n104 \n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n2\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n**LATAMED AI****CORP.**\n\n \n\n \n\n \n\n \n\nDated: May 7, 2026\n\nBy:\n\n*/s/ Kevin Rodan Levy*\n\n \n\n \n\nKevin Rodan Levy\n\n \n\n \n\n \n\nChief Executive Officer\n\n \n\n \n\n \n\n3"}